Advertisement

Revised Schedule M: What the New GMP Rules Mean for Indian Pharma

What the revised Schedule M means for Indian pharma manufacturers: PQS, QRM and compliance timelines.

By Pharmalite TeamUpdated:1 min read

Revised Schedule M in brief

The revised Schedule M aligns Indian GMP requirements with WHO-GMP: pharmaceutical quality system, quality risk management, and stricter documentation for small and medium manufacturers.

Written by

Pharmalite TeamEditor

The Pharmalite.in editorial team — study resources, jobs and drug information for pharmacy students and professionals.

More from Regulatory

Latest